Related Experiment Video
Updated: Apr 15, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
APOBEC3 genes: retroviral restriction factors to cancer drivers
Stephen Henderson1, Tim Fenton2
1Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Abstract:
The APOBEC3 cytosine deaminases play key roles in innate immunity through their ability to mutagenize viral DNA and restrict viral replication. Recent advances in cancer genomics, together with biochemical characterization of the APOBEC3 enzymes, have now implicated at least two family members in somatic mutagenesis during tumor development. We review the evidence linking these enzymes to carcinogenesis and highlight key questions, including the potential mechanisms that misdirect APOBEC3 activity to the host genome, the links to viral infection, and the association between a common APOBEC3 polymorphism and cancer risk.
Insights
APOBEC3 enzymes are crucial for innate immunity but can also cause harmful DNA mutations during cancer development. Understanding their misdirected activity is key to cancer prevention and treatment.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- APOBEC3 enzymes are critical for innate immunity, functioning as DNA deaminases that restrict viral replication.
- Recent cancer genomics and biochemical studies implicate APOBEC3 enzymes in somatic mutagenesis during tumor development.
Purpose of the Study:
- To review the evidence linking APOBEC3 enzymes to carcinogenesis.
- To highlight key questions regarding APOBEC3's role in cancer, including misdirected activity, viral links, and genetic polymorphisms.
Main Methods:
- Review of existing literature on APOBEC3 enzymes, cancer genomics, and biochemical characterization.
- Analysis of evidence connecting APOBEC3s to somatic mutagenesis and tumor development.
Main Results:
- At least two APOBEC3 family members are implicated in somatic mutagenesis in tumors.
- Evidence suggests APOBEC3 activity can be misdirected to the host genome, contributing to carcinogenesis.
Conclusions:
- APOBEC3 enzymes represent a double-edged sword in cancer, essential for immunity but potentially oncogenic.
- Further research is needed to elucidate mechanisms of misdirected APOBEC3 activity and its link to cancer risk and viral infections.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes

